Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:carmustine
|
| gptkbp:approvalYear |
1996
|
| gptkbp:ATCCode |
L01AD01
|
| gptkbp:contraindication |
hypersensitivity to carmustine
|
| gptkbp:form |
biodegradable wafer
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gliadel
|
| gptkbp:indication |
treatment of brain tumors
treatment of glioblastoma multiforme |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Eisai_Inc.
|
| gptkbp:mechanismOfAction |
antineoplastic agent
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:prescriptionStatus |
Rx-only
|
| gptkbp:routeOfAdministration |
intracranial implantation
|
| gptkbp:sideEffect |
infection
seizures wound healing complications brain edema |
| gptkbp:tradeNameOf |
carmustine implant
|
| gptkbp:bfsParent |
gptkb:carmustine
|
| gptkbp:bfsLayer |
7
|